Zimmer Partners, LP Immunocore Holdings PLC Transaction History

Zimmer Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$42.85 - $69.5 $886,995 - $1.44 Million	-20,700 Reduced 58.15%	14,900 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $1.73 Million - $2.19 Million	35,600 New	35,600 $2.13 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $41.5 $322,200 - $415,000	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$36.3 - $56.34 $363,000 - $563,400	10,000 New	10,000 $426,000

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Zimmer Partners, LP with notifications on news.